We are live on
!
Find out more
AL
Aspiriant LLC Portfolio holdings
AUM
$3.51B
1-Year Est. Return
13.98%
This Fund
S&P 500
This Quarter
Est. Return
-0.73%
1 Year Est. Return
+13.98%
3 Year Est. Return
+39.43%
5 Year Est. Return
+43.32%
10 Year Est. Return
+133.07%
AUM
$3.51B
AUM Growth
+$30.4M
(+0.87%)
Cap. Flow
+$70M
Cap. Flow
% of AUM
1.99%
Top 10 Holdings %
Top 10 Hldgs %
63.99%
Holding
355
New
36
Increased
103
Reduced
149
Closed
17
Top Buys
| 1 |
Vanguard Small-Cap Value ETF
VBR
|
+$26.6M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$23.2M |
| 3 |
iShares Core S&P US Value ETF
IUSV
|
+$10.6M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.64M |
| 5 |
iShares MSCI Global Min Vol Factor ETF
ACWV
|
+$3.92M |
Top Sells
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$3.54M |
| 2 |
Apple
AAPL
|
+$3M |
| 3 |
Microsoft
MSFT
|
+$2.43M |
| 4 |
iShares Russell 3000 ETF
IWV
|
+$1.8M |
| 5 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.61M |
Sector Composition
| 1 | Technology | 3.46% |
| 2 | Financials | 2.08% |
| 3 | Communication Services | 1.14% |
| 4 | Healthcare | 0.74% |
| 5 | Industrials | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Applied Materials
AMAT
$421B
| $1.03M | 0.03% |
3,014
-238
| -7% | -$80.1K |
|
152
Paychex
PAYX
$40.7B
| $1.02M | 0.03% |
11,107
-10
| -0.1% | -$989 |
|
153
3M
MMM
$83.4B
| $1.02M | 0.03% |
7,014
-174
| -2% | -$27.7K |
|
154
State Street Technology Select Sector SPDR ETF
XLK
$114B
| $1M | 0.03% |
7,544
-1,766
| -19% | -$249K |
|
155
Restaurant Brands International
QSR
$26B
| $966K | 0.03% |
13,072
-19
| -0.1% | -$1.33K |
|
156
Coca-Cola
KO
$351B
| $958K | 0.03% |
12,596
-1,063
| -8% | -$80.4K |
|
157
Vanguard Mega Cap Growth ETF
MGK
$32.7B
| $954K | 0.03% |
12,985
-1,425
| -10% | -$112K |
|
158
Pfizer
PFE
$143B
| $953K | 0.03% |
33,933
+5,300
| +19% | +$141K |
|
159
iShares Select Dividend ETF
DVY
$23.8B
| $947K | 0.03% |
6,255
+4
| +0.1% | +$604 |
|
160
GE Aerospace
GE
$364B
| $940K | 0.03% |
3,311
-1,175
| -26% | -$369K |
|
161
iShares S&P 500 Value ETF
IVE
$48.8B
| $936K | 0.03% |
4,432
+105
| +2% | +$22.7K |
|
162
Schwab International Equity ETF
SCHF
$65.4B
| $906K | 0.03% |
36,591
+4,958
| +16% | +$126K |
|
163
Silgan Holdings
SLGN
$4.99B
| $897K | 0.03% |
23,128
-25
| -0.1% | -$1.1K |
|
|
HDV
164
iShares Core High Dividend ETF
HDV
$14.2B
| $896K | 0.03% |
33,020
+1,145
| +4% | +$30.5K |
|
165
Capital One
COF
$128B
| $862K | 0.02% |
4,723
-234
| -5% | -$48.9K |
|
166
US Bancorp
USB
$98.4B
| $862K | 0.02% |
16,568
-1,113
| -6% | -$61.2K |
|
|
ACLX
167
DELISTED
Arcellx
ACLX
| $842K | 0.02% |
7,332
-578
| -7% | -$51K |
|
168
State Street SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
$53.4M
| $839K | 0.02% |
12,092
| – | – |
|
169
Goldman Sachs
GS
$314B
| $834K | 0.02% |
986
-12
| -1% | -$10.7K |
|
170
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.23B
| $818K | 0.02% |
5,653
| – | – |
|
171
iShares Gold Trust
IAU
$62.4B
| $815K | 0.02% |
9,239
| – | – |
|
172
Kinder Morgan
KMI
$71.9B
| $804K | 0.02% |
23,987
-1,567
| -6% | -$49K |
|
173
iShares Core Universal USD Bond ETF
IUSB
$42.8B
| $778K | 0.02% |
16,839
+2,819
| +20% | +$131K |
|
174
Vanguard Total World Stock ETF
VT
$76.6B
| $775K | 0.02% |
5,601
+472
| +9% | +$67.9K |
|
175
FedEx
FDX
$74.7B
| $775K | 0.02% |
2,174
-224
| -9% | -$77.8K |
|
Similar funds
BCP
ACA
IIM
TH
TYCC
TCM
DILIC
KCM
Aspiriant LLC's Q1 2026 Portfolio in Review
As of Q1 2026, Aspiriant LLC held 355 positions worth $3.51B, up 0.87% from $3.48B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Aspiriant LLC's Q1 2026 filing shows 36 new, 103 increased, 149 reduced and 17 closed positions. Its largest new stake was Rhythm Pharmaceuticals: 33,007 shares worth $2.87M. The largest sale was Vanguard Tax-Exempt Bond Index Fund, an estimated $3.54M.
By sector, the portfolio is most concentrated in Technology at 3.5% of assets, down from 4.1% a quarter earlier, followed by Financials and Communication Services.
- Aspiriant LLC's largest Q1 2026 buy was Rhythm Pharmaceuticals: 33,007 shares worth $2.87M.
- Aspiriant LLC added most to Vanguard Small-Cap Value ETF in Q1 2026, an estimated $26.6M increase.
- Aspiriant LLC's biggest Q1 2026 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $3.54M.
- Aspiriant LLC fully exited Brookfield in Q1 2026, selling an estimated $957K.
- Aspiriant LLC's ten largest holdings make up 64% of its $3.51B portfolio in Q1 2026.
- Aspiriant LLC opened 36 new positions and closed 17 in Q1 2026.
- Aspiriant LLC's portfolio value rose 0.87% quarter-over-quarter to $3.51B.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.